Neuromelanin imaging analyses of the substantia nigra in patients with Machado-Joseph disease
- 18 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neuroradiology
- Vol. 62 (11), 1433-1439
- https://doi.org/10.1007/s00234-020-02479-9
Abstract
Purpose Machado-Joseph disease (MJD/SCA3) is the most frequent spinocerebellar ataxia worldwide. Pathological studies revealed less melanin-containing dopaminergic neurons in the substantia nigra (SN) pars compacta in MJD/SCA3 patients. The purpose of this study was to quantify the damage in the SN reported for MJD/SCA3 patients in vivo using neuromelanin MR imaging. Methods We retrospectively reviewed the clinical information and MR imaging in sixteen MJD/SCA3 patients and fourteen healthy controls. High-resolution T1-WI of the SN were acquired using a 3-T MR system. The neuromelanin-related contrast (NRC), which was defined as the number of pixels of high-signal-intensity areas on T1-WI in the SN, was calculated semi-automatically. The NRC values were compared between MJD/SCA3 patients and normal controls. Results The NRC values were significantly lower in MJD/SCA3 patients than in healthy controls. In MJD/SCA3 patients, a significant negative correlation existed between disease durations and NRC values. No significant difference in the NRC values was revealed between the MJD/SCA3 patients with and without parkinsonism. Conclusion Neuromelanin in the SN may decrease at the early stage of the disease and continue to decrease over time with the disease duration in MJD/SCA3 patients. The NRC may be a useful biological index for monitoring MJD/SCA3.This publication has 35 references indexed in Scilit:
- The Neuropathology of Spinocerebellar Ataxia Type 3/Machado-Joseph DiseasePublished by Springer Science and Business Media LLC ,2018
- Clinical Features of Machado-Joseph DiseasePublished by Springer Science and Business Media LLC ,2018
- A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson’s diseaseNeuroscience Letters, 2016
- No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigraBrain, 2015
- Correlation between pathology and neuromelanin MR imaging in Parkinson’s disease and dementia with Lewy bodiesNeuroradiology, 2013
- Monoamine neurons in the human brain stem: anatomy, magnetic resonance imaging findings, and clinical implicationsNeuroReport, 2008
- Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's diseaseNeuroReport, 2006
- Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesisThe Lancet Neurology, 2004
- Spinocerebellar ataxia 3 and machado‐joseph disease: Clinical, molecular, and neuropathological featuresAnnals of Neurology, 1996
- CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1Nature Genetics, 1994